Navegação por Autores IPEN "FAINTUCH, BLUMA L."

Classificar por: Ordenar: Resultados:

  • IPEN-DOC 15130

    TEODORO, RODRIGO; FAINTUCH, BLUMA L. ; WIECEK, DANIELLE P.; SILVA, NATANAEL G. ; VALLEJO, NATALIA M.. Biological profile of sup(99m)TcHYNIC-betaAlA-NT (8-13) in MDA MB-231 breast cancer cell line. In: INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE; MEETING ON NUCLEAR APPLICATIONS, 9th; MEETING ON REACTOR PHYSICS AND THERMAL HYDRAULICS, 16th; MEETING ON NUCLEAR INDUSTRY, 1st, September 27 - October 2, 2009, Rio de Janeiro, RJ. Proceedings... Sao Paulo: ABEN, 2009, 2009.

    Palavras-Chave: buildup; chelating agents; experimental data; high-performance liquid chromatography; impurities; labelling; mammary glands; mice; neoplasms; peptides; radiochemistry; radionuclide kinetics; radiopharmaceuticals; small intestine; technetium 99; thin-layer chromatography; tissue distribution

    Icon

  • IPEN-DOC 18044

    FAINTUCH, BLUMA L. ; OLIVEIRA, ERICA A.; NUNEZ, EUTIMIO G.F.; MORO, ANA M.; NANDA, P.K.; SMITH, CHARLES J.. Comparison of two peptide radiotracers for prostate carcinoma targeting. Clinics, v. 67, n. 2, p. 163-170, 2012.

    Palavras-Chave: neoplasms; prostate; targets; labelling; peptides; technetium 99; comparative evaluations

    Icon

  • IPEN-DOC 21229

    FAINTUCH, BLUMA L. ; OLIVEIRA, ERICA A. ; NUNEZ, EUTIMIO G.F. ; MORO, ANA M.; NANDA, P.K.; SMITH, CHARLES J.. Comparison of two peptide radiotracers for prostate carcinoma targeting. Clinics, v. 67, n. 2, p. 163-170, 2012. DOI: 10.6061/clinics/2012(02)12

    Abstract: OBJECTIVES: Scintigraphy is generally not the first choice treatment for prostate cancer, although successful studies using bombesin analog radiopeptides have been performed. Recently, a novel peptide obtained using a phage display library demonstrated an affinity for prostate tumor cells. The aim of this study was to compare the use of a bombesin analog to that of a phage display library peptide (DUP-1) radiolabeled with technetium-99m for the treatment of prostate carcinoma. The peptides were first conjugated to S-acetyl-MAG3 with a 6-carbon spacer, namely aminohexanoic acid. METHODS: The technetium-99m labeling required a sodium tartrate buffer. Radiochemical evaluation was performed using ITLC and was confirmed by high-performance liquid chromatography. The coefficient partition was determined, and in vitro studies were performed using human prostate tumor cells. Biodistribution was evaluated in healthy animals at various time points and also in mice bearing tumors. RESULTS: The radiochemical purity of both radiotracers was greater than 95%. The DUP-1 tracer was more hydrophilic (log P = -2.41) than the bombesin tracer (log P = -0.39). The biodistribution evaluation confirmed this hydrophilicity by revealing the greater kidney uptake of DUP-1. The bombesin concentration in the pancreas was greater than that of DUP-1 due to specific gastrin-releasing peptide receptors. Bombesin internalization occurred for 78.32% of the total binding in tumor cells. The DUP-1 tracer showed very low binding to tumor cells during the in vitro evaluation, although tumor uptake for both tracers was similar. The tumors were primarily blocked by DUP- 1 and the bombesin radiotracer primarily targeted the pancreas. CONCLUSION: Further studies with the radiolabeled DUP-1 peptide are recommended. With further structural changes, this molecule could become an efficient alternative tracer for prostate tumor diagnosis.

    Icon

  • IPEN-DOC 05228

    FAINTUCH, BLUMA L. . Estudo de marcacao, biodistribuicao e analise compartimental da N-acetil cisteina marcada com Tc99m .Investigacao comparativa com MIBI-sub99mTc em modelo tumoral in vivo. 1997. Tese (Doutoramento) - Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP, Sao Paulo. 196 p. Orientador: Maria Aparecida Theodoro Marcilio de Almeida.

    Palavras-Chave: labelling; isonitriles; cysteine; technetium 99; neoplasms; uptake; rats; organs; animal tissues; radiopharmaceuticals; in vivo

    Icon

  • IPEN-DOC 13735

    SANTOS, RODRIGO L.S.R.; FAINTUCH, BLUMA L. ; TEODORO, RODRIGO. Estudos in vitro e in vivo de analogo da timidina marcada com complexo organometalico de tecnecio-99m para potencial uso em diagnostico tumoral. Revista Brasileira de Ciencias Farmaceuticas, v. 44, n. 1, p. 85-95, 2008.

    Palavras-Chave: thymidine; radiopharmaceuticals; technetium 99; organometallic compounds; tracer techniques; neoplasms; diagnosis

    Icon

  • IPEN-DOC 23929

    OLIVEIRA, ERICA A. de ; FAINTUCH, BLUMA L. ; TARGINO, ROSELAINE C.; MORO, ANA M.; MARTINEZ, RAQUEL C.R.; PAGANO, ROSANA L.; FONOFF, ERICH T.; CARNEIRO, CAMILA de G.; GARCEZ, ALEXANDRE T.; FARIA, DANIELE de P.; BUCHPIGUEL, CARLOS A.. Evaluation of GX1 and RGD‑GX1 peptides as new radiotracers for angiogenesis evaluation in experimental glioma models. Amino Acids, v. 48, n. 3, p. 821-831, 2016. DOI: 10.1007/s00726-015-2130-y

    Abstract: Gliomas are the most common type among all central nervous system tumors. The aggressiveness of gliomas is correlated with the level of angiogenesis and is often associated with prognosis. The aim of this study is to evaluate the novel GX1 peptide and the heterodimer RGD-GX1 radiolabeled with technetium-99m, for angiogenesis detection in glioma models. Radiolabeling and radiochemical controls were assessed for both radioconjugates. In vitro binding studies in glioma tumor cells were performed, as well as biodistribution in SCID mice bearing tumor cells, in order to evaluate the biological behavior and tumor uptake of the radiocomplexes. Blocking and imaging studies were also conducted. MicroSPECT/ CT images were acquired in animals with experimentally implanted intracranial tumor. Open field activity was performed to evaluate behavior, as well as perfusion and histology analysis. The radiochemical purity of both radiotracers was greater than 96 %. In vitro binding studies revealed rather similar binding profile for each molecule. The highest binding was for RGD-GX1 peptide at 120 min in U87MG cells (1.14 ± 0.35 %). Tumor uptake was also favorable for RGD-GX1 peptide in U87MG cells, reaching 2.96 ± 0.70 % at 1 h p.i. with 47 % of blocking. Imaging studies also indicated better visualization for RGD-GX1 peptide in U87MG cells. Behavior evaluation pointed brain damage and histology studies confirmed actual tumor in the uptake site. The results with the angiogenesis seeking molecule 99mTc-HYNIC-E- [c(RGDfk)-c(GX1)] were successful, and better than with 99mTc-HYNIC-PEG4-c(GX1). Future studies targeting angiogenesis in other glioma and nonglioma tumor models are recommended.

    Icon

  • IPEN-DOC 23930

    OLIVEIRA, ERICA A. de ; LAZOVIC, JELENA; GUO, LEA; SOTO, HORACIO; FAINTUCH, BLUMA L. ; AKHTARI, MASSOUD; POPE, WHITNEY. Evaluation of magnetonanoparticles conjugated with new angiogenesis peptides in intracranial glioma tumors by MRI. Applied Biochemistry and Biotechnology, 2017. DOI: 10.1007/s12010-017-2443-2

    Abstract: Angiogenesis plays a critical role in progression of malignant gliomas. The development of glioma-specific labeling molecules that can aid detection and visualization of angiogenesis can help surgical planning and improve treatment outcome. The aim of this study was to evaluate if two peptides (GX1 and RGD-GX1) linked to angiogenesis can be used as an MR-imaging markers of angiogenesis. MR imaging was performed in U87 glioblastoma-bearing NOD-SCID mice at different time points between 15 and 120 min post-injection to visualize particle distribution. GX1 and RGD-GX1 exhibited the highest accumulation in U87 glioblastoma at 120 min post i.v. administration. GX1-conjugated agents lead to higher decrease in transverse relaxation time (T2) (i.e., stronger contrast enhancement) than RGD-GX1-conjugated agents in U87 glioblastoma tumor model. In addition, we tested if U87-IDH1R132 mutated cell line had different pattern of GX1 or RGD-GX1 particle accumulation. Responses in U87-IDH1WT followed a similar pattern with GX1 contrast agents; however, lower contrast enhancement was observed with RGD-GX1 agents. The specific binding of these peptides to human glioblastoma xenograft in the brain was confirmed by magnetic resonance imaging. The contrast enhancement following injection of magnetonanoparticles conjugated to GX1 peptide matched well with CD31 staining and iron staining.

    Icon

  • IPEN-DOC 23933

    FAINTUCH, BLUMA L. ; SEO, DANIELE ; OLIVEIRA, ERICA A. de ; TARGINO, ROSELAINE C.; MORO, ANA M.. Evaluation of the influence of the conjugation site of the chelator agent HYNIC to GLP1 antagonist radiotracer for insulinoma diagnosis. Current Radiopharmaceuticals, v. 10, n. 1, p. 65-72, 2017. DOI: 10.2174/1874471010666170126143636

    Abstract: Background and Objective: Radiotracer diagnosis of insulinoma, can be done using somatostatin or glucagon-like peptide 1 (GLP-1). Performance of GLP-1 antagonists tends to be better than of agonists. Methods: We investigated the uptake of the antagonist exendin (9-39), radiolabeled with technetium-99m. Two different sites of the biomolecule were selected for chelator attachment. Results: HYNIC-beta Ala chelator attached to serine (C-terminus) of exendin, was associated with higher tumor uptake than to aspartate (N-terminus). Conclusion: The chelator position in the biomolecule influenced receptor uptake.

    Icon

  • IPEN-DOC 22802

    SCHIPER, LUIS; FAINTUCH, BLUMA L. ; BADARO, ROBERTO J. da S.; OLIVEIRA, ERICA A. de ; CHAVEZ, VICTOR E.A.; CHINEN, ELISANGELA; FAINTUCH, JOEL. Functional investigation of bone implant viability using radiotracers in a new model of osteonecrosis. Clinics, v. 71, n. 10, p. 617-625, 2016. DOI: 10.6061/clinics/2016(10)11

    Abstract: OBJECTIVES: Conventional imaging methods are excellent for the morphological characterization of the consequences of osteonecrosis; however, only specialized techniques have been considered useful for obtaining functional information. To explore the affinity of radiotracers for severely devascularized bone, a new mouse model of isolated femur implanted in a subcutaneous abdominal pocket was devised. To maintain animal mobility and longevity, the femur was harvested from syngeneic donors. Two technetium-99m-labeled tracers targeting angiogenesis and bone matrix were selected. METHODS: Medronic acid and a homodimer peptide conjugated with RGDfK were radiolabeled with technetium-99m, and biodistribution was evaluated in Swiss mice. The grafted and control femurs were evaluated after 15, 30 and 60 days, including computed tomography (CT) and histological analysis. RESULTS: Radiolabeling achieved high (>95%) radiochemical purity. The biodistribution confirmed good blood clearance 1 hour after administration. For Tc-99m-hydrazinonicotinic acid (HYNIC)-E-[c(RGDfK)(2), remarkable renal excretion was observed compared to Tc-99m-methylene diphosphonate (MDP), but the latter, as expected, revealed higher bone uptake. The results obtained in the control femur were equal at all time points. In the implanted femur, Tc-99m-HYNIC-E-[c(RGDfK)(2) uptake was highest after 15 days, consistent with early angiogenesis. Regarding Tc-99m-MDP in the implant, similar uptake was documented at all time points, consistent with sustained bone viability; however, the uptake was lower than that detected in the control femur, as confirmed by histology. CONCLUSIONS: 1) Graft viability was successfully diagnosed using radiotracers in severely ischemic bone at all time points. 2) Analogously, indirect information about angiogenesis could be gathered using Tc-999m-HYNIC-E-[c(RGDfK)(2). 3) These techniques appear promising and warrant further studies to determine their potential clinical applications.

    Palavras-Chave: skeleton; implants; viability; tracer techniques; radioactive tracers; necrosis; mice; animals; angiogenesis; femur; technetium isotopes; technetium 99; biological models; images

    Icon

  • IPEN-DOC 14527

    NUNEZ, EUTIMIO G.F.; FAINTUCH, BLUMA L. ; TEODORO, RODRIGO; WIECEK, DANIELLE P.; MARTINELLI, JOSE R.; SILVA, NATANAEL G. da ; CASTANHEIRA, CLAUDIA E.; OLIVEIRA FILHO, RENATO S. de; PASQUALINI, ROBERTO. Influence of colloid particle profile on sentinel lymph node uptake. Nuclear Medicine and Biology, v. 36, n. 7, p. 741-747, 2009.

    Palavras-Chave: colloids; dextran; lymph nodes; particle size; radiopharmaceuticals; rats; rhenium sulfides; technetium 99; tin; tissues; distribution; uptake

    Icon

  • IPEN-DOC 11820

    SANTOS, RODRIGO L.S.R.; FAINTUCH, BLUMA L. ; TEODORO, RODRIGO; MURAMOTO, EMIKO; NUNES, IVANE V.S.. Invasive evaluation of 99mTc(CO)3-thymidine analog in a lung cancer model. Radiologia Brasileira, v. 39, n. Suppl., 2, p. 93-94, 2006.

    Palavras-Chave: technetium 99; thymidine; radiopharmaceuticals; labelled compounds; neoplasms; images; cell proliferation; lungs; mice

    Icon

  • IPEN-DOC 19184

    FAINTUCH, BLUMA L. ; SOSA PEREIRA, NILDA P. ; FAINTUCH, SALOMAO; MURAMOTO, EMIKO; SILVA, CONSTANCIA P.G. . Lanreotide and octreotide complexed with technetium-99m: labeling stability and biodistribution studies. Revista Brasileira de Ciencias Farmaceuticas, v. 40, n. 1, p. 101-110, 2004.

    Palavras-Chave: endocrine diseases; somatostatin; peptides; labelling; technetium 99; radiopharmaceuticals; diagnosis; nuclear medicine

    Icon

  • IPEN-DOC 26705

    FAINTUCH, BLUMA L. ; FAINTUCH, SALOMAO. Nanotheranostics in oncology and drug development for imaging and therapy. In: FAINTUCH, JOEL (Ed.); FAINTUCH, SALOMAO (Ed.). Precision Medicine for Investigators, Practitioners and Providers. London, UK: Academic Press, 2020. p. 453-458, cap. 44. DOI: 10.1016/B978-0-12-819178-1.00044-7

    Icon

  • IPEN-DOC 16453

    FAINTUCH, BLUMA L. ; TEODORO, RODRIGO; OLIVEIRA, ERICA A. de; FERNANDEZ NUNEZ, EUTINMIO G.; FAINTUCH, JOEL. Neovascularization after ischemic injury. Evaluation with sup(99m)Tc-HYNIC-RGD. Acta Cirúrgica Brasileira, v. 26, n. 1, p. 58-63, 2011.

    Palavras-Chave: ischemia; diagnosis; technetium; labelling; scintiscanning; rats

    Icon

  • IPEN-DOC 17841

    TEODORO, RODRIGO; FAINTUCH, BLUMA L. ; NUNEZ, EUTIMIO G.F.; QUEIROZ, RODRIGO G.. Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators. Nuclear Medicine and Biology, v. 38, n. 1, p. 113-120, 2011.

    Palavras-Chave: radiopharmaceuticals; technetium 99; radiochemical analysis; chelating agents

    Icon

  • IPEN-DOC 23935

    SEO, DANIELE ; FAINTUCH, BLUMA L. ; OLIVEIRA, ERICA A. de; FAINTUCH, JOEL. Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity. Nuclear Medicine and Biology, v. 49, p. 57-64, 2017. DOI: 10.1016/j.nucmedbio.2017.03.002

    Abstract: Introduction: Radiolabeled GLP-1 and its analog Exendin-4, have been employed in diabetes and insulinoma. No protocol in conventional Diet-Induced Obesity (DIO), and Diet-Restricted Obesity (DRO), has been identified. Aiming to assess pancreatic beta cell uptake in DIO and DRO, a protocol was designed. Methods: GLP-1-βAla-HYNIC and HYNIC-βAla-Exendin-4 were labeled with technetium-99m. Four Swiss mouse models were adopted: Controls (C), Alloxan Diabetes Controls (ADC), DIO and DRO. Biodistribution and ex-vivo planar imaging were documented. Results: Radiolabeling yield was in the range of 97% and both agents were hydrophilic. Fasting Blood Glucose (FBG) was 79.2 ± 8.2 mg/dl in C, 590.4 ± 23.3 mg/dl in ADC, 234.3 ± 66.7 mg/dl in DIO, and 96.6 ± 9.3 in DRO (p = 0.010). Biodistribution confirmed predominantly urinary excretion. DIO mice exhibited depressed uptake in liver and pancreas, for both radiomarkers, in the range of ADC. DRO only partially restored such values. 99mTc-HYNIC-βAla-Exendin-4 demonstrated better results than GLP-1-βAla-HYNIC-99mTc. Conclusions: 1) Diet-induced obesity remarkably depressed beta cell uptake; 2) Restriction of obesity failed to normalize uptake, despite robust improvement of FBG; 3) HYNIC-βAla-Exendin-4 was the most useful marker; 4) Further studies are recommended in obesity and dieting, including bariatric surgery.

    Palavras-Chave: alloxan; biomedical radiography; blood; design; diet; excretion; glucose; ice; labelling; liver; metabolic diseases; mice; pancreas; surgery; technetium; technetium 99; uptake; yields

    Icon

  • IPEN-DOC 17842

    NUNEZ, EUTIMIO G.F.; FAINTUCH, BLUMA L. ; TEODORO, RODRIGO; WIECEK, DANIELLE P.; SILVA, NATANAEL G. ; PAPADOPOULOS, MINAS; PELECANOU, MARIA; PIRMETTIS, IOANNIS; OLIVEIRA FILHO, RENATO S. de; DUATTI, ADRIANO; PASQUALINI, ROBERTO; QUEIROZ, RODRIGO G.. Parameters optimization defined by statistical analysis for cysteine-dextran radiolabeling with technetium tricarbonyl core. Applied Radiation and Isotopes, v. 69, n. 4, p. 663-669, 2011.

    Palavras-Chave: cysteine; dextran; radiopharmaceuticals; labelling; technetium 99; statistics

    Icon

  • IPEN-DOC 22579

    FERNANDEZ, EUTIMIO G.; FAINTUCH, BLUMA L. ; OLIVEIRA, RELMA T. de; WIECEK, DANIELLE P. ; TEODORO, RODRIGO ; OLIVEIRA FILHO, RENATO S. de. Present and future of the radio-molecules used in detection of sentinel lymphatic nodes. Latin American Journal of Pharmacy, v. 28, n. 2, p. 298-303, 2009.

    Palavras-Chave: neoplasms; melanomas; metastases; radiopharmaceuticals; lymph nodes; detection; tomography; lymphatic system; animals

    Icon

  • IPEN-DOC 12051

    TEODORO, RODRIGO; FAINTUCH, BLUMA L. ; QUEIROZ, RODRIGO G.; MURAMOTO, EMIKO; MORGANTI, LIGIA ; NASCIMENTO, NANCI do . Radiochemical and biological evaluation of Ter-Cys-RGD derivarive labeled with the precursor [sup(99m)Tc(Hsub(2)O)sub(3)(CO)sub(3)]sup(+). In: INTERNATIONAL NUCLEAR ATLANTIC CONFERENCE; MEETING ON NUCLEAR APPLICATIONS, 8th/ MEETING ON REACTOR PHYSICS AND THERMAL HYDRAULICS, 15th, Sept. 30 - Oct. 5, 2007, Santos, SP. Proceedings... Sao Paulo: ABEN, 2007, 2007.

    Palavras-Chave: experimental data; labelling; mice; radiochemistry; radiopharmaceuticals; scintiscanning; technetium 99; thin-layer chromatography; tumor cells; uptake

    Icon

  • IPEN-DOC 23934

    FAINTUCH, BLUMA L. ; OLIVEIRA, ERICA A. ; MUNOZ, JULIAN E.; TRAVASSOS, LUIZ R.; TABORDA, CARLOS P.. Radiochemical pharmacokinetic profile of P10 peptide with antifungal properties. Medical Mycology, v. 52, n. 5, p. 1-5, 2014. DOI: 10.1093/mmy/myu024

    Abstract: Paracoccidioidomycosis (PCM) is a chronic granulomatous disease that is caused by the thermally dimorphic fungus Paracoccidioides brasiliensis. It is endemic in some countries of Latin America and can cause a high-burden fungal infection with significant morbidity and mortality. The peptide P10, which demonstrates immune protection against experimental PCM, was radiolabeled with a radioisotope and evaluated in vivo. The radiolabeling was conducted to trace the pharmacokinetics of the molecule in principal organs and tissues. This was achieved with high radiochemical purity. Biodistribution and scintigraphic imaging showed fast blood clearance that was mainly renal; however, hepatobiliar excretion was also, withmarked uptake in cervical lymph nodes. This profile may be useful for the development of a prophylactic drug or vaccine for patients exposed to PCM.

    Icon

A pesquisa no RD utiliza os recursos de busca da maioria das bases de dados. No entanto algumas dicas podem auxiliar para obter um resultado mais pertinente.

É possível efetuar a busca de um autor ou um termo em todo o RD, por meio do Buscar no Repositório , isto é, o termo solicitado será localizado em qualquer campo do RD. No entanto esse tipo de pesquisa não é recomendada a não ser que se deseje um resultado amplo e generalizado.

A pesquisa apresentará melhor resultado selecionando um dos filtros disponíveis em Navegar

Os filtros disponíveis em Navegar tais como: Coleções, Ano de publicação, Títulos, Assuntos, Autores, Revista, Tipo de publicação são autoexplicativos. O filtro, Autores IPEN apresenta uma relação com os autores vinculados ao IPEN; o ID Autor IPEN diz respeito ao número único de identificação de cada autor constante no RD e sob o qual estão agrupados todos os seus trabalhos independente das variáveis do seu nome; Tipo de acesso diz respeito à acessibilidade do documento, isto é , sujeito as leis de direitos autorais, ID RT apresenta a relação dos relatórios técnicos, restritos para consulta das comunidades indicadas.

A opção Busca avançada utiliza os conectores da lógica boleana, é o melhor recurso para combinar chaves de busca e obter documentos relevantes à sua pesquisa, utilize os filtros apresentados na caixa de seleção para refinar o resultado de busca. Pode-se adicionar vários filtros a uma mesma busca.

Exemplo:

Buscar os artigos apresentados em um evento internacional de 2015, sobre loss of coolant, do autor Maprelian.

Autor: Maprelian

Título: loss of coolant

Tipo de publicação: Texto completo de evento

Ano de publicação: 2015

Para indexação dos documentos é utilizado o Thesaurus do INIS, especializado na área nuclear e utilizado em todos os países membros da International Atomic Energy Agency – IAEA , por esse motivo, utilize os termos de busca de assunto em inglês; isto não exclui a busca livre por palavras, apenas o resultado pode não ser tão relevante ou pertinente.

95% do RD apresenta o texto completo do documento com livre acesso, para aqueles que apresentam o significa que e o documento está sujeito as leis de direitos autorais, solicita-se nesses casos contatar a Biblioteca do IPEN, bibl@ipen.br .

Ao efetuar a busca por um autor o RD apresentará uma relação de todos os trabalhos depositados no RD. No lado direito da tela são apresentados os coautores com o número de trabalhos produzidos em conjunto bem como os assuntos abordados e os respectivos anos de publicação agrupados.

O RD disponibiliza um quadro estatístico de produtividade, onde é possível visualizar o número dos trabalhos agrupados por tipo de coleção, a medida que estão sendo depositados no RD.

Na página inicial nas referências são sinalizados todos os autores IPEN, ao clicar nesse símbolo será aberta uma nova página correspondente à aquele autor – trata-se da página do pesquisador.

Na página do pesquisador, é possível verificar, as variações do nome, a relação de todos os trabalhos com texto completo bem como um quadro resumo numérico; há links para o Currículo Lattes e o Google Acadêmico ( quando esse for informado).

ATENÇÃO!

ESTE TEXTO "AJUDA" ESTÁ SUJEITO A ATUALIZAÇÕES CONSTANTES, A MEDIDA QUE NOVAS FUNCIONALIDADES E RECURSOS DE BUSCA FOREM SENDO DESENVOLVIDOS PELAS EQUIPES DA BIBLIOTECA E DA INFORMÁTICA.

O gerenciamento do Repositório está a cargo da Biblioteca do IPEN. Constam neste RI, até o presente momento 20.950 itens que tanto podem ser artigos de periódicos ou de eventos nacionais e internacionais, dissertações e teses, livros, capítulo de livros e relatórios técnicos. Para participar do RI-IPEN é necessário que pelo menos um dos autores tenha vínculo acadêmico ou funcional com o Instituto. Nesta primeira etapa de funcionamento do RI, a coleta das publicações é realizada periodicamente pela equipe da Biblioteca do IPEN, extraindo os dados das bases internacionais tais como a Web of Science, Scopus, INIS, SciElo além de verificar o Currículo Lattes. O RI-IPEN apresenta também um aspecto inovador no seu funcionamento. Por meio de metadados específicos ele está vinculado ao sistema de gerenciamento das atividades do Plano Diretor anual do IPEN (SIGEPI). Com o objetivo de fornecer dados numéricos para a elaboração dos indicadores da Produção Cientifica Institucional, disponibiliza uma tabela estatística registrando em tempo real a inserção de novos itens. Foi criado um metadado que contém um número único para cada integrante da comunidade científica do IPEN. Esse metadado se transformou em um filtro que ao ser acionado apresenta todos os trabalhos de um determinado autor independente das variáveis na forma de citação do seu nome.

A elaboração do projeto do RI do IPEN foi iniciado em novembro de 2013, colocado em operação interna em julho de 2014 e disponibilizado na Internet em junho de 2015. Utiliza o software livre Dspace, desenvolvido pelo Massachusetts Institute of Technology (MIT). Para descrição dos metadados adota o padrão Dublin Core. É compatível com o Protocolo de Arquivos Abertos (OAI) permitindo interoperabilidade com repositórios de âmbito nacional e internacional.

1. Portaria IPEN-CNEN/SP nº 387, que estabeleceu os princípios que nortearam a criação do RDI, clique aqui.


2. A experiência do Instituto de Pesquisas Energéticas e Nucleares (IPEN-CNEN/SP) na criação de um Repositório Digital Institucional – RDI, clique aqui.